What is the EBS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Emergent BioSolutions Inc. (EBS) price will be around $8.43 in the next 2 weeks. This means it will decrease by -2.6443418013856927 from the last closing price. This prediction may vary from other time period filters for EBS stock.

What can be the highest Possible price of EBS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, EBS can achieve the highest price of $9.02 which is 4.126281731876207 higher than last closing price. This prediction may vary from other time period filters for EBS stock.

What can be the lowest Possible price of EBS stock in next 2 weeks?

As per the forecast and algorithmic analysis, EBS stock price can be as low as $7.88 which is -9.061458713693378 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for EBS stock.

Will EBS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that EBS stock will lose-2.6443418013856927 in the next 2 weeks. This prediction may vary from other time period filters for EBS stock.

What is EBS stock last closing price?

Last closing price of EBS stock was $8.66.

What is EBS stock price prediction?

EBS stock price prediction means predicting the future closing prices of EBS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of EBS stock in a certain time period.

How we predict EBS stock future prices?

If you are searching for EBS stock forecast, analysis or price prediction, then you might be wondering what Emergent BioSolutions Inc. (EBS) will do in the future. Our EBS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This EBS price prediction will likely answer most of your questions.

How frequent we update EBS stock predictions?

We are updating the forecasts for the EBS stock on daily basis.

Is using ML forecasting for EBS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for EBS stock same for all the time periods?

No, the prediction for EBS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Emergent BioSolutions Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$8.665.22%Since 2 Weeks

Predicted Price$8.43-2.64%For 2 Weeks

Upper Predicted Price$9.024.13%For 2 Weeks

Lower Predicted Price$7.88-9.06%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of EBS will decline by -2.64% over the next 2 Weeks and hit $8.43 by Tuesday, April 28, 2026. In that time frame, EBS's share price is expected to range between $7.88 and $9.02.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 28, 2026	7.88	8.43	9.02
Apr 27, 2026	7.82	8.37	8.93
Apr 24, 2026	7.51	8.06	8.61
Apr 23, 2026	8.15	8.69	9.25
Apr 22, 2026	8.12	8.65	9.21
Apr 21, 2026	7.91	8.46	9.00
Apr 20, 2026	7.85	8.40	8.94
Apr 17, 2026	7.62	8.09	8.63
Apr 16, 2026	8.18	8.71	9.27
Apr 15, 2026	8.10	8.67	9.20

EBS shares fell -1.44% in Thursday, April 16, 2026's trading session, dropping from a previous close of $8.66 to move at $8.54. The stock demonstrated notable intraday movement (see EBS's key stats for a full breakdown), fluctuating between $8.43 and $8.80, a +4.33% trading range. While recent weeks have seen some volatility, EBS has managed to secure a +2.83% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 800.59K shares changing hands, 250.56K more than the previous session. This amounted to $6.83M in total market activity.

Will EBS Continue Its Upward Trend?

According to analyst ratings and projections for EBS, Emergent BioSolutions Inc. shares are anticipated to increase by +5.35%, potentially reaching $9.02 per share by April 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for EBS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the EBS stock forecast, now is a good time to buy EBS stock because its current trading price is +1.23% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EBS covering social and institutional perspectives.

EBS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into EBS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.80% to 54.90%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.96%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.45%, maintains a neutral outlook for the long term. Insights into EBS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Emergent BioSolutions Short-Term Forecasts

EBS Forecast For Next 5 Days

Our algorithm anticipates Emergent BioSolutions (EBS) stock could hit $6.68 by Apr 23, 2026. This represents a -21.68% fall from today's price, following a -10.41% change over the past five days.

EBS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Emergent BioSolutions Inc. (EBS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $6.04, which would mean a -29.23% decrease from the current price of $8.54. Projections for this period range from a high of $7.79 to a low of $4.21.

EBS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Emergent BioSolutions's price over the next three months point to a rise. EBS stock is expected to peak at $34.13 on Jul 16, 2026 after potentially dipping to $17.41 on Apr 24, 2026. On average, EBS is likely to trade around $23.96 in the coming 90 days.

Emergent BioSolutions Stock Forecast 2025

Based on our predictive models, Emergent BioSolutions (EBS) is expected to trade between $17.41 and $51.83 throughout 2026. This would result in an average price of $31.48, potentially offering investors a +268.83% return from current levels.

Emergent BioSolutions Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Emergent BioSolutions Inc. (EBS) is positioned to show a strong performance in April 2026. The price is predicted to move between $17.41 and $19.36, settling at an average of $18.34. This could translate to a +114.88% gain.

May 2026

Based on current market signals, Emergent BioSolutions Inc. is projected to trend may 2026. We forecast a trading range from $18.93 to $23.24, with a likely average price of $20.81. Investors could expect a potential return of +143.82%.

June 2026

Our predictive algorithms indicate Emergent BioSolutions Inc. stock may see a shift in June 2026. The expected range spans $24.12–$28.56, with an average target of $26.91. This represents a positive outlook and a possible gain of +215.29%.

July 2026

Analyzing established trends, Emergent BioSolutions Inc. looks set to move in July 2026. Projections place the stock between $26.03 and $37.78, averaging around $32.30. This suggests a +278.44% gain from current levels.

August 2026

Market indicators suggest Emergent BioSolutions Inc. could experience notable changes during August 2026. Prices could fluctuate within $30.66 to $36.06, with a midpoint forecast of $33.07. The stock might deliver a +287.46% gain.

September 2026

Forecasting for September 2026, models estimate that Emergent BioSolutions Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.85 and $35.57, averaging $29.32. This signals a positive trajectory with potential returns around +243.53%.

October 2026

According to our latest forecast models, Emergent BioSolutions Inc. (EBS) is positioned to show a strong performance in October 2026. The price is predicted to move between $29.43 and $41.14, settling at an average of $33.32. This could translate to a +290.39% gain.

November 2026

Based on current market signals, Emergent BioSolutions Inc. is projected to trend november 2026. We forecast a trading range from $36.81 to $51.83, with a likely average price of $40.72. Investors could expect a potential return of +377.09%.

December 2026

Our predictive algorithms indicate Emergent BioSolutions Inc. stock may see a shift in December 2026. The expected range spans $36.31–$51.78, with an average target of $41.45. This represents a positive outlook and a possible gain of +385.65%.

January 2027

Analyzing established trends, Emergent BioSolutions Inc. looks set to move in January 2027. Projections place the stock between $38.56 and $52.62, averaging around $42.81. This suggests a +401.58% gain from current levels.

February 2027

Market indicators suggest Emergent BioSolutions Inc. could experience notable changes during February 2027. Prices could fluctuate within $33.74 to $46.20, with a midpoint forecast of $36.75. The stock might deliver a +330.58% gain.

March 2027

Forecasting for March 2027, models estimate that Emergent BioSolutions Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.63 and $39.93, averaging $25.45. This signals a positive trajectory with potential returns around +198.18%.

April 2027

According to our latest forecast models, Emergent BioSolutions Inc. (EBS) is positioned to show a strong performance in April 2027. The price is predicted to move between $27.68 and $38.51, settling at an average of $29.84. This could translate to a +249.62% gain.

EBS's history of dividends and stock splits also plays a role in long-term investor confidence.